PD-L1 - CHO Recombinant Cell Line | 60543

PD-L1 - CHO Recombinant Cell Line | 60543 | Gentaur US, UK & Europe Disrtribition

Category: Immunotherapy/Cell Line

Application: Screen PD-L1 antibodies for binding affinity and biological assays.

Background: The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance. The PD-1:PD-L1/2 pathway is also involved in regulating autoimmune responses, making these proteins promising therapeutic targets for a number of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes.

Description: Recombinant CHO-K1 cells constitutively expressing human PD-L1 (Programmed Cell Death 1 Ligand 1, CD274, B7 homolog 1 (B7- H1), GenBank accession #NM_014143).

Product Type: Cell Line

Shippement Condition: -80°C